27 Feb 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Global eye health company, Bausch + Lomb, has appointed Mr Robert Bertolini as president and chief financial officer. He will oversee the company's finance, information technology and global quality and operations (GQO) functions. Mr Bertolini, who assumes CFO responsibilities from Mr Brian J Harris, will report to Bausch + Lomb's chief executive officer, Mr Brent Saunders.
"Bob Bertolini's extensive strategic, operational and transformative leadership experience as a CFO of one of the world's leading publicly traded healthcare companies will enable Bausch + Lomb to further unlock our potential and accelerate our performance. I've had the opportunity to work closely with Bob over many years. We are gratified to have an executive of his caliber join our team at this pivotal period in our history," said Mr Saunders.
Mr Bertolini said that, "Under Brent's leadership, Bausch + Lomb has made tremendous progress over the last few years, and I'm looking forward to working with him and the entire Bausch + Lomb management team to take the company to the next level. We have a compelling opportunity to realize Bausch + Lomb's vision of becoming the best global eye health company, for our customers and the patients they serve. I am excited and honored to become part of this team."
Mr Bertolini was previously executive vice president and chief financial officer at Schering-Plough from 2003 until its merger with Merck & Co in 2009. During his tenure, Mr Bertolini worked as a business partner with the chief executive officer in all aspects of transforming the company's operations. He had responsibility for key financial areas including tax, accounting and financial asset management, among other areas; built world-class finance and information technology functions; and led business development and strategy.